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Metabolism of polyunsaturated fatty acids results in 
biosynthesis of mediators with different physiological 
effects. These metabolites include prostaglandins, pros-
tacyclins, isoprostanes and others that are important sig-
nalling molecules and regulate a variety of physiological 
and pathophysiological processes including inflamma-
tion. Prostaglandins and isoprostanes are produced by 
either non-enzymatic lipid peroxidation or by enzyme-in-
duced peroxidation (cyclooxygenases and lipoxygenas-
es). They are used as biomarkers of oxidative stress. The 
aim of our study was to assess the effect of eicosapen-
taenoic acid (EPA) supplementation with added benzo(a)
pyrene (BaP) on HepG2 cells by using a UHPLC/MS-TOF 
method. This rapid and simple method was developed 
for the identification, separation and quantification of 
8-iPGF3α, PGF3α, 8-isoPGF2α and 5-iPF2α in cultured 
cells. The UHPLC/MS-TOF method was validated. The cal-
culated limit of detection was in the range of 0.16–0.50 
ng/mL, precision (% RSD): 1.2–2.1% and recoveries bet-
ter than 88%. This method empowered qualitative and 
quantitative analysis of the selected individual prosta-
glandins derived from arachidonic acid and eicosapen-
taenoic acid from cell extracts.
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INTRODUCTION
Environmental and occupational exposure to chemi-
cals may induce various diseases in individuals and pop-
ulations leading to major public health problems. Polycy-
clic aromatic hydrocarbons (PAHs) are a large family of 
toxic compounds generated from the combustion of or-
ganic materials, diesel exhaust, and industrial waste. They 
are widely spread pollutants present in the atmosphere, 
water and soil. 
Some PAHs are classified as human carcinogens, and 
also elicit a broad spectrum of toxic responses in hu-
mans and animals. Exposure to PAH results in a variety 
of molecular responses in an organism such as enzyme 
activation, oxidation, and/or signal transduction (Duan et 
al., 2010; Hanzalowa et al., 2010; Kang et al., 2010; Pleil 
et al., 2010; Teranishi et al., 2010). 
Many of these responses are mediated by the aryl 
hydrocarbon receptor (AhR)/aryl hydrocarbon nuclear 
translocator (ARNT) signalling pathway. AhR partici-
pates in NF-κB signalling pathways regulating inflamma-
tion, immune responses, apoptosis, survival, and prob-
ably other functions. This aspect of biological roles of 
AhR is not clearly described and well known (Kung et 
al., 2009; Puga et al., 2009; Casado et al., 2010; Quintana 
& Sherr 2013; Nguyen 2013). 
A toxic potential of a chemical is related to its initial 
interaction with the target cell plasma membrane. Struc-
tural and chemical (lipid) composition of the membrane 
determines the overall rate of uptake of the xenobiotic 
from the extracellular space. The intramembranous re-
tention of the compound directly influences the nature 
and rate of partitioning of the agent into intracellular 
space, where metabolic activation, detoxification, or di-
rect reaction with macromolecules ensues. Binding of 
toxic substances, particularly those of lipophilic nature, 
to plasma membranes may result in perturbation of 
membrane-associated cell-regulatory mechanisms such as 
transport and activity of membrane-associated enzymes 
(Davidson et al., 2012; Duan et al., 2010; Eyster, 2007). 
Apart from their carcinogenicity, PAHs may exert 
their negative effects on the human organism by in-
duction of the oxidative stress. Oxidative stress result-
ing from an imbalance between prooxidants, including 
reactive oxygen species (ROS), and antioxidants in the 
organism may affect DNA, lipids, and proteins as well. 
Lipid peroxidation has two major impacts on the cell. 
It changes the properties of the cellular membranes, af-
fects their structure and the activity of membrane-bound 
proteins, and it causes the formation of other reactive 
intermediates that propagate oxidative stress (Cadet et al., 
2010; Circu & Aw, 2010). Among the markers of lipid 
peroxidation, isoprostanes are considered to be the most 
reliable. They are formed by a free-radical attack on ar-
achidonic acid localized in cellular membranes. Current-
ly, 8-iso prostaglandin F2α is the best characterized and 
the most often studied isoprostane (Brooks et al., 2008; 
Guichardant & Lagerde, 2009; Milne et al., 2006; Dahl & 
van Breemen, 2010). 
The aim of this research was the evaluation of a rap-
id method for identification of lipid derivatives of eicos-
apentaenoic acid: prostaglandin F3α (PGF3α), 8-iso pros-
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taglandin F3α (8-iPGF3α), and of arachidonic acid: 8-iso 
prostaglandin F2α (8-iPGF2α) and 5-isoprostane F2α 
(5-iPF2α) in HepG2 cultured cells, using ultrahigh per-
formance liquid chromatography coupled to mass spec-
trometry with a time of flight mass analyzer (UHPLC/
MS-TOF). Prostaglandin F2α-d9 (PGF2α-d9) and 8-iso 
prostaglandin F2α-d4 (8iPGF2 α-d4) were used as the in-
ternal standards (ISs) throughout.
MATERIALS AND METHODS
Reagents. Prostaglandin F3α (PGF3α), 8-iso prosta-
glandin F3α (8-iPGF3α), 8-iso prostaglandin F2α (8-iPG-
F2α), 5-isoprostane F2α (5-iPF2α), prostaglandin F2α-d9 
(PGF2α-d9) and 8-iso prostaglandin F2α-d4 (8iPGF2α 
-d4) were obtained from Cayman Chemical Company 
(Michigan, USA). The standards’ concentration ranged 
between 0.31–5.0 ng/ml when using solutions of ana-
lytes (0.31, 0.63, 1.25, 1.5, 2.0, 2.5, 5.0). LC-MS grade 
methanol, ethanol, electrospray calibrant solution, bu-
tylated hydroxytoluene (BHT), eicosapentaenoic acid 
sodium salt and benzo(a)pyrene, potassium hydroxide, 
hydrogen peroxide, dimethyl sulfoxide (DMSO) were 
purchased from Sigma-Aldrich (St. Louis, USA). Analyti-
cal grade formic acid was supplied by Merck (Darmstadt, 
Germany). Water (18.2 MΩcm, TOC< 5ppm) was ultra-
purified and filtered through a Milli-Q Plus system (Mil-
lipore, Bedford, USA).
Standard solutions. IsoP stock solutions (5 µg/
mL) were prepared in ethanol with 0.1% formic acid 
and stored in a freezer (–20ºC). Standard solutions were 
prepared daily by appropriately diluting stock solutions 
with methanol containing 5% formic acid. 
Cultured cells. Human hepatocellular carcinoma cells 
used (American Type Cell Culture: Hep G2, HB-8065) 
were between 10th and 25th passages. Hep G2 cells were 
cultured in Eagle’s Minimum Essential Medium supple-
mented with 10% FBS and 1% antibiotic solution (100 
IU/mL penicillin, 0.1 mg/mL streptomycin) ( ATTC; 
Gibco). Cells were maintained at 37ºC in humidified at-
mosphere of 5% CO2 in air and were finally seeded into 
a 6-well plate (Sarsted) at a density of 5 × 105 cells/well 
in 2 mL of medium. At every step of the procedure, cell 
morphology was investigated by an inverted light mi-
croscope (Olympus). Cell viability during culturing was 
assessed with Trypan Blue Exclusion Test. HepG2 cells 
were treated with 4 µL of eicosapentaenoic acid (EPA 
sodium salt dissolved in ethanol to the final concentra-
tion of 40 µM/µL) for 24h combined with 1 µL of ben-
zo(a)pyrene dissolved in DMSO to the final concentra-
tion of 20 µM/µL (for 2 h). Control cultures received 
the same concentration of ethanol (the final content did 
not exceed 0.12% v/v) and DMSO (the final content 
did not exceed 0.05% v/v) as experimental cells.
We used nontoxic concentrations for both EPA and 
BaP (effect on time-dose dependent study not present-
ed). After incubation, the cells and media were collected. 
Trypsin–0.05 % EDTA solution was used to detach ad-
herent cultures.
Cytotoxicity assay (MTT — 3-[4,5-dimethylth-
iazol-2yl]-2,5-diphenyl tetrazolium bromide test). 
EPA was added to the cells at appropriate concentrations 
and incubated for 24 h, then 20 µM BaP was added for 
2 h. Cells cultured in the medium alone constituted the 
positive control (100% of growth); cells treated with 20 
mM/l of hydrogen peroxide were employed as the nega-
tive control. The procedure was done as described above 
(Paśko et al., 2013). 
Isolation of isoprostanes was done according to 
the method proposed by Milne et al., 2006. Prior to ex-
traction, 10 µl of 0.01% BHT was added to each sam-
ple to prevent further oxidation. Then, PGF2α-d9 and 
8iPGF2α-d4 (20 ng/µl) was added to samples as an in-
ternal standard. Solid phase extraction (SPE) was done 
using Bond Elute Plexa cartridges (Agilent Technolo-
gies). Next, SPE samples were reconstituted in 200 µl of 
methanol containing 5% formic acid prior to UHPLC/
MS-TOF analysis.
UHPLC/MS-TOF conditions. Identification and 
determination of isoprostanes was performed using an 
UltiMate 3000 RS liquid chromatography system (Di-
onex, USA) coupled to a mass spectrometer with a 
time of flight mass analyzer (MicrOTOF-Q II, Bruker, 
Germany). Separation of the studied prostaglandins was 
carried out on a Synergi 4u Hydro-RP 80A column 
(150 × 2.0 mm I.D, Phenomenex, USA) at 40ºC. The 
mobile phase was prepared by mixing methanol and 
0.01 % formic acid according to a gradient program 
(MeOH: 0 min — 20%; 18 min — 100%, 20 min — 
20% to 22 min). The flow rate of the mobile phase was 
set to 0.2 ml/min. For each analysis, 10 µL of sample 
solution was injected by an autosampler. Electrospray 
was used as an ion source. The optimized conditions 
were as follows: nebulizer pressure: 2.0 bar, dry gas: 
7.0 l/min and temperature of dry gas: 220ºC. The pro-
file spectra were acquired in negative mode in the mass 
range of 50–1000 m/z with mass resolving power over 
18 000. Mass calibration was performed using a mixture 
of 10 mM sodium formate and isopropanol before each 
run. Data were processed by Data Analysis software 
(Bruker, Germany) and extracted ion chromatograms of 
all analytes were plotted using [M-H]– and calculated by 
IsotopicPattern software (Bruker, Germany). 
RESULTS AND DISCUSSION
Development of UHPLC/MS-TOF method
At the beginning, to identify the studied IsoPs in low 
quantities the ESI-MS-TOF parameters were optimized 
using a single variable procedure for all 8 tested param-
eters of ESI source and mass spectrometer. Obtaining 
the highest abundance of m/z values corresponding to 
[M-H]– ions of the IsoPs provided a high sensitivity of 
the developed method. The best conditions of the tested 
Table 1.  Optimal mass spectrometry (ESI-MS-TOF) conditions
Parameter Optimal value
ESI
End plate offset [V] –500
Capillary voltage [V] +4800
Nebulizer pressure [Bar] 2.0
Dry gas flow [l/min] 7.0
Dry gas temperature [°C] 220
MS-TOF
Hexapole RF [Vpp] 600
Transfer time [μs] 30
Pre pulse storage [μs] 13
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analytical system are shown in Ta-
ble 1.
The UHPLC separation method 
was developed based on the chro-
matographic conditions published 
by Cao et al. (2008), Taylor et al. 
(2010) and Dahl et al. (2010). In 
order to separate the four isopros-
tanes analyzed (8-iPGF3α, PGF3α, 
8-iPGF2α, 5-iPF2α) and the inter-
nal standards (PGF2α-d9, 8iPG-
F2α-d4), the mobile phase compo-
sition (ACN, MeOH, 0.01% formic 
acid and 0.01% acetic acid), flow 
rate (0.2, 0.3, 0.4 ml/min), column 
temperature (25, 30, 35, 40, 45, 
50ºC) and time of measurement 
(22, 24, 26, 32 min) were tested 
(for final, optimal condition see: 
Section UHPLC/MS-TOF con-
ditions). The [M-H]- masses with 
the defined retention time (Rt) for 
the studied IsoPs were: 8-iPGF3α 
m/z = 351.217±0.005 (Rt = 16.3 
min), PGF3α m/z = 351.217±0.005 
(Rt = 17.1 min), 8-iPGF2α m/z = 
353.232±0.005 (Rt = 17.2 min), 
5-iPF2α m/z = 353.232±0.005 (Rt 
= 17.4 min), PGF2α-d9 m/z = 
362.289±0.005 (Rt = 17.2 min), 
8iPGF2α-d4 m/z = 357.257±0.005 
(Rt = 18.0 min). The chromato-
graphic separation of the four IsoPs 
studied is depicted in Fig. 1. 
Validation of the UHPLC/MS-TOF 
method
The optimized UHPLC/MS-
TOF method was validated in 
terms of specificity, linearity, lim-
its of detection and quantification, 
precision, recovery and matrix ef-
fects. The validation parameters 
were investigated at the concen-
tration of 2.5 ng/ml, using stand-
ard solutions of the tested IsoPs. 
In order to define the recovery 
and matrix effects parameters, cell 
samples were analyzed. The cal-
culated validation parameters are 
collected in Table 2. 
Specificity. Specificity and selec-
tivity of the method were assayed. 
To determine the effect of matrix 
components on the identification 
results, comparative analysis was 
carried out for a blank sample and 
the standard solutions as well as of 
the cell extracts. On the basis of 
the recorded chromatograms, no 
significant influence of other sample 
components on quantification was 
observed. 
Linearity. Linearity of the meth-
od for each IsoP was tested in the 
concentration range 0.31–5.0 ng/ml 
Table 2.  Validation parameters of the UHPLC-MS-TOF method
IsoP 8-iPGF3α PGF3α 8-iPGF2α 5-iPF2α
LOD
[ng/ml] 0.33 0.50 0.18 0.16
LOQ
[ng/ml] 1.02 1.62 0.61 0.38
Linearity
[ng/ml] LOQ — 5.0
Slope 0.0951 0.1553 0.0754 0.0367
Intercept –0.0515 –0.0936 0.0171 0.0907
R2 0.9947 0.9967 0.9986 0.9932
% RSD (at 2.5 ng/ml), n=5 
intraday 1.4 2.1 1.6 1.2
interday 1.7 2.7 1.9 1.5
R %
(at 2.5 ng/ml), n=4 90.0 88.5 91.2 89.3
ME %
(at 2.5 ng/ml), n=4 110 118 106 112
Figure 1 (a). Chromatogram of separation of the four studied IsoPs using UHPLC/MS-
TOF method. (b) Chromatogram example of an experimental sample.
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using standard solutions of analytes (0.31, 0.63, 1.25, 1.5, 
2.0, 2.5, 5.0). For each concentration of standard solu-
tion there were three injections. Calibration curves were 
calculated using peak-area ratios (drug/IS). PGF2α-d9 
was used as internal standard for 8-iPGF3α and PGF3α; 
8iPGF2α-d4 was the internal standard for 8-iPGF2α and 
5-iPFα. The concentration of ISs was 20 ng/ml. Calibra-
tion curve for 8-iPGF2α is presented at Fig. 2. 
Limit of detection and limit of determination. 
Limits of detection (LOD) and determination (LOQ) 
were obtained experimentally, after the analysis of stan-
dard solutions of the studied isoprostanes. Limit of de-
termination was calculated at the base of signal/noise as 
three and the limit of detection at the base signal/noise 
as ten.
Precision. Precision (% RSD) was investigated at the 
concentration level of 2.5 ng/ml. Precision of the UH-
PLC-MS-TOF method (% RSD) was calculated as repro-
ducibility of the determined concentration and estimated 
by analysis of five separately prepared standard solutions 
of IsoP. The measurements were repeated on four dif-
ferent days. In this way, intraday and interday precision 
was evaluated. 
Accuracy (Recovery). Accuracy of the method was 
defined in terms of isoprostanes recovery (R %). It was 
expressed by a ratio of the analytical signal obtained 
for IsoP which was added to a blank sample before ex-
traction, to the analytical signal obtained for the same 
studied IsoP which was added after extraction in the 
same concentration (2.5 ng/ml, including enrichment 
factor), at n = 4, as the standard solution.
Matrix effects. Matrix effects (% ME) were assayed by 
the post-extraction addition approach. They were evaluat-
ed by comparing the mean peak area of the analyte spiked 
after extraction (into extracted blank sample) with the 
mean peak area of the same studied IsoP which was in a 
standard solution in the same concentration (2.5 ng/ml), 
expressed in percentage, at n = 4. The matrix effect val-
ues less than 100% represent ionization suppression and 
values below 100% reveal signal enhancements.
Application of the UHPLC/MS-TOF method for cell 
cultureanalysis
The developed and validated UHPLC/MS-TOF meth-
od was then used to identify and determine prostaglan-
dins in HepG2. Qualitative analysis was carried out by 
comparing the retention time of each IsoP at the chro-
matogram with the retention time of the reference stan-
dard of IsoP and based on the ion mass value [M-H]– of 
the IsoP. Quantitative analysis was performed using the 
validation parameters described previously. The isopros-
tane content was calculated using a calibration curve 
based on the registered analytical signal (peak area of 
the IsoP/peak area of the IS). The application of the 
UHPLC/MS-TOF method enabled the identification 
and determination of prostaglandin (8-iPGF3α) formed 
by EPA in human HepG2 cells (at the concentration 
4.43 ng/ml) (Fig. 1b). 
Due to the strong procancerogenic potential and re-
activity of benzo(a)pyrene metabolites, as well as the 
susceptibility of polyunsaturated fatty acids to oxidizing, 
this study was undertaken. According to the available 
literature, a molecular mechanism of carcinogenesis of 
polycyclic aromatic hydrocarbons (PAHs) is not clearly 
understood. Knowledge on isoprostanes’ metabolism and 
other active fatty acid products still remains incomplete. 
A mechanism of action wasn’t also clarified for lipoxins, 
resolvins and other anti-inflammatory derivative polyun-
saturated fatty acids. Therefore, studies that could con-
tribute to explaining and revealing the pathomechanism 
of illnesses involving inflammation are advisable and 
necessary. 
The results of our investigation have shown that sup-
plementation with EPA for 24h and adding  20 µM 
BaP for 2 h did not inhibit the growth and proliferation 
of tumor cell line Hep G2. In the control samples of 
Hep G2 and in the cells supplemented with EPA, iso-
prostanes were not found. In the cells supplemented 
with EPA with addition of BaP, active lipid derivatives 
were identified. We detected lipid derivatives from EPA 
-prostaglandin PGF3α and isoprostane 8-iPGF3α as well 
as from arachidonic acid (8-iPGF2α and 5-iPF2α-VI). 
These findings strongly suggest that benzo(a)pyrene acts 
via cyclooxygenase pathway (formation of PGF3α) and 
propagates oxidative stress by lipid oxidation. Oxidative 
stress caused by lipid peroxidation through free radicals 
is believed to be one of the key factors underlying sever-
al acute and chronic diseases, which cause high morbidi-
ty and mortality, and oxidative stress has been implicated 
in the ageing process. 
In the typical Western diet, n-6 polyunsaturated fat-
ty acids (PUFAs) dominate, resulting in the release of 
pro-inflammatory arachidonic acid-derived metabolites. 
n-3 fatty acids might have a protective or even thera-
peutic effect. This may be attributable to their impact on 
mediators of inflammation. The dietary intake of fatty 
acids affects production of eicosanoids, which are po-
tent immune mediators being mainly synthesized from 
eicosapentaenoic acid (EPA; C20:5 n-3) and arachidonic 
acid (AA; C20:4 n-6). Docosahexaenoic acid (DHA) and 
EPA are n-3 PUFAs mainly derived from fish oils that 
competitively inhibit n-6 PUFA arachidonic acid metab-
olism, thus reducing generation of the inflammatory leu-
kotrienes and prostaglandins as much as the production 
of cytokines from inflammatory cells (Gao et al., 2006; 
Kitz  et al., 2010; Serhan et al., 2011).
EPA not only can replace arachidonic acid in phos-
pholipid bilayers but is also a competitive inhibitor of 
cyclooxygenase, reducing the production of 2-series PGs 
and thromboxane, in addition to the 4-series leukot-
rienes. These studies suggest that the beneficial effects of 
n-3 fatty acids may be mediated, in part, by the anti-in-
flammatory effects of oxidized EPA (Connor et al., 2007; 
Gao et al., 2006; Song et al., 2009; Sheran et al., 2011).
While the prostaglandins are produced as a result of 
cyclooxygenase enzyme activity, isoprostanes are generally 
thought to form non-enzymatically by free radical-mediat-
Figure 2. Calibration curve for 8-iPGF2α.
Vol. 60       815Lipid derivatives in HepG2 cells
ed peroxidation of arachidonic acid and other unsaturated 
fatty acids. Separate evidence has suggested that cycloo-
xygenase activity may also contribute to isoprostane pro-
duction in selected tissues. Due to the potential role of 
isoprostanes in the pathogenesis of disease, their cellular 
signalling pathways and biological effects have been under 
investigation (Eyster, 2007; Davidson et al., 2012).
Toxicity of aromatic hydrocarbons often involves cel-
lular alternations associated with oxidative stress (Parrish 
et al., 1998). Although many of PAHs have been shown 
to interfere with immune responses, the mechanisms 
underlying immunotoxicity of these compounds are not 
fully understood (Hwang et al., 2007). Kelley et al. (1997) 
discovered that benzo(a)pyrene up-regulates cyclooxy-
genase-2 gene expression in oral epithelial cells. Dendele 
et al. (2013) observed protective action of n-3 fatty ac-
ids on benzo(a)pyrene-induced apoptosis. The authors 
showed that n-3 PUFA interferes with BaP-induced tox-
ic effect through alternations of H+ homeostasis and in-
hibition of the N+/H+ exchanger (NHE-1) pathway.
Supplementation of fatty acids with EPA has been 
beneficial for cell viability, and it remains the subject 
of future studies. Study of eicosapentaenoic acid deriva-
tives and their physiological role may provide valuable 
insights into the role of EPA in human physiology and 
pathophysiology. The identity and activity of key media-
tors is a crucial issue, and novel intermediates associated 
with prostanoid, cannabinoid, resolving and endoperox-
ide pathways are providing new therapeutic opportunities 
(Eyster, 2007; Sehran et al., 2011; Davidson et al., 2012). 
In summary we demonstrate, for the first time, that 
eicosapentaenoic acid (EPA) has an anti-oxidative stress 
effect under benzo(a)pyrene exposition. Our findings 
strongly suggest that EPA plays a role in enhancement 
of the anti-oxidant defence and has a high therapeutic 
value, and thus should be one of the therapeutic ap-
proaches due to its dynamically modulatory properties.
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